3,4-dihydroxyphenylalanine reverses the motor deficits in Pitx3-deficient aphakia mice: behavioral characterization of a novel genetic model of Parkinson's disease

J Neurosci. 2005 Feb 23;25(8):2132-7. doi: 10.1523/JNEUROSCI.3718-04.2005.

Abstract

Parkinson's disease (PD) is a neurodegenerative disease characterized by a loss of dopaminergic neurons in the substantia nigra. There is a need for genetic animal models of PD for screening and in vivo testing of novel restorative therapeutic agents. Although current genetic models of PD produce behavioral impairment and nigrostriatal dysfunction, they do not reproduce the loss of midbrain dopaminergic neurons and 3,4-dihydroxyphenylalanine (L-DOPA) reversible behavioral deficits. Here, we demonstrate that Pitx3-deficient aphakia (ak) mice, which have been shown previously to exhibit a major loss of substantia nigra dopaminergic neurons, display motor deficits that are reversed by L-DOPA and evidence of "dopaminergic supersensitivity" in the striatum. Thus, ak mice represent a novel genetic model exhibiting useful characteristics to test the efficacy of symptomatic therapies for PD and to study the functional changes in the striatum after dopamine depletion and L-DOPA treatment.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Antiparkinson Agents / therapeutic use*
  • Ataxia / drug therapy
  • Ataxia / genetics
  • Benserazide / therapeutic use
  • Blindness / genetics
  • Corpus Striatum / drug effects*
  • Corpus Striatum / physiopathology
  • Dopamine / physiology
  • Homeodomain Proteins / genetics
  • Levodopa / therapeutic use*
  • Locomotion
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Mice, Neurologic Mutants
  • Parkinsonian Disorders / drug therapy*
  • Parkinsonian Disorders / genetics
  • Psychomotor Performance / drug effects
  • Substantia Nigra / drug effects
  • Substantia Nigra / physiopathology
  • Transcription Factors / deficiency*
  • Transcription Factors / genetics

Substances

  • Antiparkinson Agents
  • Homeodomain Proteins
  • Transcription Factors
  • homeobox protein PITX3
  • Levodopa
  • Benserazide
  • Dopamine